Krsnaa Diagnostics partners with Apulki Healthcare to transform cancer and cardiac care

Krsnaa Diagnostics Limited, one of India’s leading providers of diagnostic services, has made a bold move by acquiring a significant stake in Apulki Healthcare Private Limited, which is lauded as India’s first Public-Private Partnership (PPP) dedicated to cancer and cardiac care hospitals. This partnership is set to radically change the landscape of specialized healthcare, particularly in oncology and cardiology, by offering advanced diagnostic services 24/7 under one roof. The announcement, made on September 25, 2024, reveals that this collaboration will cater to the unmet demand for specialized healthcare, especially in densely populated metropolitan areas such as Pune and Mumbai, with the first two hospitals in these cities boasting over 125 beds each.

Under the terms of this partnership, Krsnaa Diagnostics becomes the exclusive provider of diagnostic services at Apulki’s state-of-the-art cancer and cardiac hospitals for more than 30 years. This guarantees Krsnaa’s continued leadership in India’s fast-growing oncology and cardiac diagnostic sectors while providing them with access to Apulki’s planned network of 10+ hospitals across the country. The first two hospitals will focus on delivering comprehensive diagnostic services like MRI, PET CT, Cardiac CT, and Advanced Pathology, ensuring high-quality patient care.

The partnership’s goal is to accelerate early detection of cancer and cardiac conditions, improve treatment accuracy, and enhance survival rates through timely and precise diagnoses. The 24/7 availability of cutting-edge diagnostic technologies at these hospitals will significantly improve healthcare outcomes for patients from all socioeconomic backgrounds.

Yash Mutha, Joint Managing Director of Krsnaa Diagnostics Ltd, emphasized that the acquisition is more than a strategic investment; it’s a game-changer for India’s healthcare system. He stated that Krsnaa is positioning itself at the forefront of the rapidly expanding cancer and cardiac care sector. Mutha further noted that the investment will be funded entirely through internal accruals over the next few months, without any strain on the company’s cash flow. This partnership marks a significant milestone for Krsnaa as it expands its presence in premium urban areas and establishes advanced diagnostic centers that will serve both hospital and retail patients.

Kinjal Babariya, Director of Apulki Healthcare, expressed her excitement over the partnership. She believes that the collaboration will accelerate growth and set new benchmarks in cancer and cardiac diagnostics and treatment in India. She also highlighted the unique advantage of the partnership’s PPP model, which integrates diagnostics and treatment under one roof, thereby eliminating barriers to fragmented healthcare and improving patient outcomes.

Krsnaa Diagnostics, established in 2011, has rapidly grown into one of India’s largest diagnostic service providers, with over 2,900 centers across 18 states and union territories. Their mission to provide accessible, affordable, and high-quality diagnostic services has positioned them as a trusted name in the healthcare sector. Krsnaa’s expertise in both Radiology and Pathology, combined with its cutting-edge technology, has helped the company deliver clinical excellence nationwide. The company’s diagnostic services are enhanced by a cloud-based PACS workflow, ensuring fast and accurate reporting from specialists across the globe. Additionally, Krsnaa is home to India’s first CAP-accredited lab operating under a PPP model and the largest NABH-accredited tele-radiology hub in Pune.

This partnership is expected to set a new precedent in the Indian healthcare industry by integrating diagnostics and treatment at a scale never seen before, while improving access to critical care services across the country.

Expert Opinion: The Future of Healthcare in India is Bright

Healthcare experts explained that the partnership between Krsnaa Diagnostics and Apulki Healthcare represents a “paradigm shift” in India’s approach to specialized care. By offering integrated services, the collaboration could set a national example of how the private and public sectors can work together to tackle serious health challenges like cancer and heart disease. Furthermore, this model could inspire similar initiatives in other healthcare sectors, ensuring that high-quality, affordable healthcare is accessible to more Indians.